Metropolitan Life Insurance Company (MetLife)’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-201
| Closed | -$11.8K | – | 765 |
|
|
2024
Q1 | $11.8K | Buy |
+201
| New | +$11.8K | ﹤0.01% | 2076 |
|
|
2023
Q3 | – | Sell |
-194
| Closed | -$13.1K | – | 2413 |
|
|
2023
Q2 | $13.1K | Hold |
194
| – | – | ﹤0.01% | 2155 |
|
|
2023
Q1 | $90.6K | Sell |
194
-37
| -16% | -$17.3K | ﹤0.01% | 1041 |
|
|
2022
Q4 | $92.5K | Hold |
231
| – | – | ﹤0.01% | 1094 |
|
|
2022
Q3 | $75.2K | Hold |
231
| – | – | ﹤0.01% | 1188 |
|
|
2022
Q2 | $61K | Hold |
231
| – | – | ﹤0.01% | 1367 |
|
|
2022
Q1 | $69.4K | Sell |
231
-560
| -71% | -$168K | ﹤0.01% | 1407 |
|
|
2021
Q4 | $279K | Sell |
791
-31
| -4% | -$10.9K | ﹤0.01% | 1783 |
|
|
2021
Q3 | $210K | Sell |
822
-160
| -16% | -$40.9K | ﹤0.01% | 2027 |
|
|
2021
Q2 | $653K | Buy |
982
+64
| +7% | +$42.6K | 0.01% | 1334 |
|
|
2021
Q1 | $797K | Sell |
918
-38
| -4% | -$33K | 0.01% | 1112 |
|
|
2020
Q4 | $887K | Hold |
956
| – | – | 0.01% | 965 |
|
|
2020
Q3 | $983K | Sell |
956
-56
| -6% | -$57.6K | 0.02% | 753 |
|
|
2020
Q2 | $1.03M | Buy |
1,012
+62
| +7% | +$62.8K | 0.02% | 727 |
|
|
2020
Q1 | $825K | Sell |
950
-39
| -4% | -$33.9K | 0.02% | 779 |
|
|
2019
Q4 | $1.06M | Sell |
989
-20
| -2% | -$21.4K | 0.02% | 862 |
|
|
2019
Q3 | $933K | Buy |
1,009
+44
| +5% | +$40.7K | 0.02% | 900 |
|
|
2019
Q2 | $1.09M | Hold |
965
| – | – | 0.02% | 844 |
|
|
2019
Q1 | $1.31M | Sell |
965
-12
| -1% | -$16.3K | 0.02% | 717 |
|
|
2018
Q4 | $1.13M | Buy |
977
+13
| +1% | +$15K | 0.02% | 737 |
|
|
2018
Q3 | $1.46M | Hold |
964
| – | – | 0.02% | 702 |
|
|
2018
Q2 | $1.51M | Buy |
964
+84
| +10% | +$131K | 0.02% | 689 |
|
|
2018
Q1 | $1.02M | Buy |
880
+21
| +2% | +$24.3K | 0.01% | 894 |
|
|
2017
Q4 | $1.02M | Sell |
859
-928
| -52% | -$1.1M | 0.01% | 875 |
|
|
2017
Q3 | $2.4M | Buy |
1,787
+182
| +11% | +$245K | 0.02% | 880 |
|
|
2017
Q2 | $1.3M | Buy |
1,605
+139
| +9% | +$112K | 0.01% | 1108 |
|
|
2017
Q1 | $903K | Hold |
1,466
| – | – | 0.01% | 1281 |
|
|
2016
Q4 | $784K | Hold |
1,466
| – | – | 0.01% | 1434 |
|
|
2016
Q3 | $759K | Hold |
1,466
| – | – | 0.01% | 1441 |
|
|
2016
Q2 | $601K | Buy |
1,466
+117
| +9% | +$48K | ﹤0.01% | 1569 |
|
|
2016
Q1 | $718K | Hold |
1,349
| – | – | 0.01% | 1356 |
|
|
2015
Q4 | $1.03M | Hold |
1,349
| – | – | 0.01% | 1172 |
|
|
2015
Q3 | $739K | Sell |
1,349
-31
| -2% | -$17K | 0.01% | 1369 |
|
|
2015
Q2 | $811K | Buy |
+1,380
| New | +$811K | 0.01% | 1433 |
|
|
2015
Q1 | – | Sell |
-399
| Closed | -$272K | – | 2280 |
|
|
2014
Q4 | $272K | Buy |
+399
| New | +$272K | ﹤0.01% | 2191 |
|